Intravenous Solutions Market, By Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), By Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), By Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), By End-user (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis 2019 - 2027

  • Published On : Sep 2019 |
  • Pages : 215 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Intravenous Solution Market – Insights

Intravenous solutions (IV) are administered in patients to provide sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. Adoption of inorganic growth strategies such as collaborations and acquisitions by key players in order to expand their portfolio of intravenous solutions is expected to drive growth of the global intravenous solutions market. For instance, in April 2015, Baxter International Inc. and France-based Laboratoire Aguettant SAS, entered into a licensing and distribution agreement for trace elements, which are essential micronutrients used in parenteral nutrition (PN) therapy.

The global intravenous solution market size was valued at US$ 8,372.0 million in 2019, and is expected to witness a CAGR of 6.1% over the forecast period (2019 – 2027).

Global Intravenous Solution Market Share (%) Analysis, By Solution, 2019

Intravenous Solutions  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing Launches and Regulatory Approvals for Intravenous Solution Injection is expected to Drive Growth of the Global Intravenous Solution Market

Increasing approvals for intravenous solution injections from regulatory authorities is expected to drive the global intravenous solution market growth over the forecast period. For instance, in 2015, B. Braun Medical Inc, a subsidiary of B.Braun, operating in infusion therapy and pain management, announced the U.S. FDA approval for its 70% Dextrose for Injection in a 2L flexible container. 70% Dextrose for Injection is an intravenous solution indicated as a source of calories and fluid replenishment.

Launches of new intravenous solution injections for the treatment of various diseases such as dehydration, gastrointestinal diseases is expected to drive the intravenous solution market growth over the forecast period. For instance, in 2017, Fresenius Kabi USA, LLC, offers medicines and technologies for infusion, transfusion, and clinical nutrition, launched Vecuronium Bromide for Injection in the U.S. The drug is indicated for maintenance of neuromuscular blockade and paralysis.

Intravenous Solution Market - Restraints

Growth of the global intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.

Intravenous Solution Market- Regional Insights

On the basis of region, the global intravenous solution market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Europe is expected to hold a dominant position in the global intravenous solution market over the forecast period, owing to increasing launches of parenteral (intravenous) nutrition (PN) products. For instance, in 2016, Baxter International Inc, a global leader in PN therapy, launched NUMETA G13E 300 mL in Europe. NUMETA G13E is the only ready-to-use parenteral (intravenous) nutrition (PN) product for preterm infants (less than 37 weeks gestation age).

Among region, Asia Pacific is expected to foresee a rapid growth in the intravenous solution market, owing to increasing launches of technologically advanced intravenous solutions by key players. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered as smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.

Global Intravenous Solution Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Intravenous Solutions  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Intravenous Solution Market - Competitive Landscape

Key players operating in the global intravenous solution market include Baxter International Inc, ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited.

Report Description

Intravenous solutions are fluids, which are administrated to a patient directly into the venous circulation. These fluids are sterile, nonpyrogenic solutions used for fluid replenishment and caloric supply in single dose container for intravenous administration. Intravenous therapy is ideal for patients suffering from nutritional deficiency and dehydration. There are various types of intravenous solutions available in the market such as sodium chloride, lactated ringers, dextrose in water, and others.

Market Dynamics

Increasing prevalence of diarrhoea is expected to boost the global intravenous solution market growth over the forecast period. For instance, according to the World Health Organization (WHO), in May 2017, there were around 1.7 billion annual cases of childhood diarrheal disease across the globe.

Moreover, according to an article published in the Lancet Infectious Diseases, September 2018, diarrhoea was the third leading cause of disability-adjusted life year (DALYs) in 2016, which accounted for 74.4 million DALYs, globally. According to the same source, diarrhoea was the eighth leading cause of death, which accounted for 1,655,944 deaths in 2016. 

Increasing cost of vitamin C intravenous therapy is expected to hinder the global intravenous solution market growth. For instance, in 2017, the China government took regulatory action of lowering vitamin C production owing to environmental concerns. This led to increase in prices of vitamin C by around 300% over the year. Furthermore, China produces 95% of the world’s vitamin C, which is used in food products, dietary supplements, and pharmaceuticals. The price of vitamin C was US$ 3.50 per kg in October 2016, which increased to US$ 12 per kg by September 2017, owing to environmental issues, which decreased China’s 30% of the vitamin C production.

Key features of the study:

  • This report provides in-depth analysis of the global intravenous solution market, market size (US$ Mn), and compound annual growth rate (CAGR %) over the forecast period (2019 – 2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global intravenous solution market  based on the following parameters–company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Baxter International Inc. ICU Medical, Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global intravenous solution market report caters to various stakeholders in this industry, such as investors, product manufacturers, distributors, and suppliers for global intravenous solution market , research and consulting firms, new entrants, and financial analysts

 Detailed Segmentation:

  • Global Intravenous Solution Market , By Solution Type:
    • Saline
      • Normal Saline (0.9% NaCl)
      • Hypertonic Saline
    • Dextran
    • Lactated Ringer’s
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and Trace Elements
    • Mixed Solutions
  • Global Intravenous Solution Market , By Bag Type:
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
  • Global Intravenous Solution Market , By Application:
    • Basic IV Solution
    • Nutritional IV Solution
    • Blood IV Solution
    • Drug IV Solution
    • Irrigation IV Solution
  • Global Intravenous Solution Market , By End-user:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Home Care Settings
  • Global Intravenous Solution Market , By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
    • Middle East
      • By Country/Region:
        • GCC
        • Israel
        • Rest of Middle East
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Solution Type :
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag Type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End-user:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
  • Company Profiles
    • Baxter International Inc.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • ICU Medical, Inc.
    • B. Braun Melsungen Ag
    • Grifols, S.A.
    • Fresenius Kabi USA, LLC
    • Vifor Pharma Management Ltd.
    • JW Life Science
    • Amanta Healthcare
    • Axa Parenterals Ltd.
    • Salius Pharma Private Limited.

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Solution Type
      • Market Snippet, By Bag Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Industry Trend
    • Impact Analysis
    • Regulatory Scenario
    • Key Developments
    • Epidemiology
    • Porter’s Five Forces Analysis
  4.  Global Intravenous Solution Market, By Solution Type, 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Saline
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • Normal Saline (0.9% NaCl)
          •  Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
        • Hypertonic Saline
          •  Introduction
          • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Dextran
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Lactated Ringer’s
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Amino Acid
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Vitamins & Minerals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Heparin and trace elements
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Mixed Solutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  5. Global Intravenous Solution Market, By Bag Type 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Large Volume Bags (greater than 250ml)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Small Volume Bags (less than 250ml)
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  6. Global Intravenous Solution Market, By Application 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Basic IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Nutritional IV Solution
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Blood IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Drug IV Solution
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Irrigation IV Solution
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  7. Global Intravenous Solution Market, By End User 2019 – 2027, (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Clinics
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Ambulatory Surgery Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
    • Home care Settings
      • Introduction    
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
  8. Global Intravenous Solution Market, By Region, 2019 – 2027 (US$ Million)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Regional Trends
    • North America
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Solution Type, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Bag Type , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Application , 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Million)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  9. Competitive Landscape
    • Company Profiles
      • Baxter International Inc.*
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • ICU Medical, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • B. Braun Melsungen Ag
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Grifols, S.A.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Fresenius Kabi USA, LLC
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Vifor Pharma Management Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • JW Life Science
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Amanta Healthcare
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Axa Parenterals Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Salius Pharma Private Limited.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
    • Analyst Views
  10. Global Intravenous Solution Market , By Region, 2019 – 2027 (US$ Million)
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 34 market data tables and 35 figures on "Intravenous Solution Market” - Global forecast to 2027”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.